Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors

Genes Chromosomes and Cancer

Volumn 23, Issue 3, 1998, Pages 239-243

  Halachmi, Naomi ^a   Halachmi, Sarel ^a   Evron, Ella ^a   Cairns, Paul ^a   Okami, Kenji ^a   Saji, Motoyasu ^a   Westra, William H ^a   Zeiger, Martha A ^a   Jen, Jin ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC MUTATION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID TUMOR; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; SEQUENCE ANALYSIS, DNA; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031661833     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199811)23:3<239::AID-GCC5>3.0.CO;2-2     Document Type: Article

References (20)

1. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Issacs W, Schwab D, Sidransky D., (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat Genet 11:210-212.
2. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997-5000.
3. Dahia PLM, Marsh DJ, Zhend Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C, Eng C (1997) Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 57:4710-1713.
4. Gray IC, Phillips SMA, Lee SJ, Neoptolemos JP, Weissenbach J, Spurr NK (1995) Loss of chromosomal region 10q23-25 in prostate cancer. Cancer Res 55:4800-4803.
5. Knudson AG Jr, Hethcote HW, Brown BW (1975) Mutation and childhood cancer: A probabilistic model for the incidence of retinoblastoma. Proc Natl Acad Sci USA 72:5116-5120.
6. Li DM, Sun H (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phophatase regulated by transforming growth factor β1. Cancer Res 57:2124-2129.
7. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
8. Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64-67.
9. Marsh DJ, Zheng Z, Zedenius J, Kremer H, Padberg GW, Larsson C, Longy M, Eng C (1997) Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas. Cancer Res 57:500-503.
10. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D (1995) 5' CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686-692.
11. Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, Eeles RA, Hodgsen S, Mulvihill JJ, Murday VA, Tucker MA, Mariman EC, Starink TM, Ponder BA, Ropers HH, Kremer H, Longy M, Eng C (1996) Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 13:114-116.
12. Nelen MR, van Staveren WCG, Peeters EA, Ben Hassel M, Gorlin RJ, Hamm H, Lindboe CF, Frins JP, Sijmons RH, Woods DJ, Mariman EC, Padberg GW, Kremer H (1997) Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Molec Genet 6:1383-1387.
13. Rahseed BK, Fuller JN, Friedman AH, Bigner DD, Bigner SH (1992) Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosomes Cancer 5:75-82.
14. Senapathy P, Shapiro MB, Harris NL (1990) Splice junctions, branch point sites, and exons: Sequence statistics, identification, and applications to genome project. Methods Enzymol 183:252-278.
15. Sogol PB, Sugawara M, Gordon HE, Shellow WV, Hernandez F, Hershman JM (1983) Cowden's disease: Familial goiter and skin hamartomas - A report of three cases. West J Med 139:324-328.
16. Starink TM, van der Veen JP, Arwert F, de Waal LP, de Lange GG, Gille JJ, Eriksson AW (1986) The Cowden syndrome: A clinical and genetic study in 21 patients. Clin Genet 29:222-233.
17. Steck PA, Perhouse MA, Jasser AS, Alfred Young WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV (1997) Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362.
18. van der Riet P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, Sidransky D (1994a) Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 54:1156-1158.
19. van der Riet P, Karp D, Farmer E, Wei Q, Grossman L, Tokino K, Ruppert JM, Sidransky D (1994b) Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p.53 allele. Cancer Res 54:25-27.
20. Zedenius J, Wallin G, Svensson A, Bovee J, Hoog A, Backdahl M, Larsson C (1996) Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors. Hum Genet 97:299-303.